Bleeding Gastric Varices Clinical Trial
Official title:
Phase III Study of the Efficacy of Endoscopic Ultrasound (EUS) Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed
Consecutive patients who meet the eligibility criteria will be enrolled into the study. All
patients with gastric varices with no history of gastric variceal bleed (Group C) will
undergo Endoscopic ultrasound and Upper Gastrointestinal Endoscopy at baseline, at the end
of first year and at the end of study.
The patients who presented to Institute of Liver and Biliary Sciences with gastric variceal
bleed or develop Gastric Variceal bleed during hospital stay will be randomized into Group
-A (conventional Upper Gastrointestinal Endoscopy + Glue) and Group-B (Endoscopic Ultrasound
followed by Upper Gastrointestinal Endoscopy+Glue) therapy for gastric varices. Total 90
patients will be enrolled and randomized into group A and Group B after resuscitation and
urgent Upper Gastrointestinal Endoscopy with standard therapy for bleeding gastric varices
to achieve hemostasis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02364297 -
TIPS in Fundal Variceal Bleeding (the TFB Study)
|
N/A | |
Active, not recruiting |
NCT03705078 -
"Early TIPS" Versus Glue Obliteration to Prevent Rebleeding From Gastric Varices
|
N/A | |
Recruiting |
NCT01298271 -
A Randomized Trial of GVS Alone vs. Propranolol
|
Phase 4 |